⌘K

Login Start Free

Home/Filings/4/0001553878-14-000022

4//SEC Filing

ALNYLAM PHARMACEUTICALS, INC. 4

Accession 0001553878-14-000022

$ALNYCIK 0001178670operating

View on SEC.gov Company Profile

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 6:12 PM ET

Size

20.3 KB

Accession

0001553878-14-000022

Insider Transaction Report

Form 4

Period: 2014-11-18

ALNYLAM PHARMACEUTICALS, INC.ALNY

SVP, Chief Business Officer

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2014-11-18−3,639→ 150,609 total
Exercise: $15.99Exp: 2020-06-11→ Common Stock (3,639 underlying)
Exercise/Conversion
Common Stock
2014-11-18$7.10/sh+2,500$17,750→ 6,405 total
Sale
Common Stock
2014-11-18$90.30/sh−5,413$488,811→ 8,492 total
Exercise/Conversion
Stock Option (Right to Buy)
2014-11-18−2,500→ 12,500 total
Exercise: $7.10Exp: 2021-11-30→ Common Stock (2,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2014-11-18−3,861→ 1,728 total
Exercise: $9.14Exp: 2020-12-08→ Common Stock (3,861 underlying)
Exercise/Conversion
Common Stock
2014-11-18$9.14/sh+3,861$35,290→ 10,266 total
Sale
Common Stock
2014-11-18$91.08/sh−4,485$408,496→ 4,007 total
Sale
Common Stock
2014-11-18$91.79/sh−102$9,362→ 3,905 total
Exercise/Conversion
Common Stock
2014-11-18$15.99/sh+3,639$58,188→ 13,905 total

Holdings

Common Stock
(indirect: By Managed Account)
1,766

Footnotes (6)

[F1]The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2013.
[F2]Sale prices ranged from $89.69 to $90.68.
[F3]Sale prices ranged from $90.69 to $91.53.
[F4]Sale prices ranged from $91.72 to $91.79.
[F5]The reporting person owns 1,766 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
[F6]The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

Entity typeoperating

Related Parties

1

filerCIK 0001178670

Filing Metadata

Form type: 4
Filed: Nov 18, 7:00 PM ET
Accepted: Nov 19, 6:12 PM ET
Size: 20.3 KB

View on SEC.gov